Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Stock Market News For June 23, 2017

Published 06/22/2017, 11:26 PM
Updated 07/09/2023, 06:31 AM

The Nasdaq finished in the green for consecutive sessions on Thursday, boosted primarily by gain in health care shares. Healthcare shares posted gain following the release of Senate’s Healthcare Bill, aimed to repeal key sections of Obama’s Affordable Care Act.

The Dow and the S&P 500 closed marginally lower, dragged down by decline in financials and consumer staples shares. Meanwhile, investors digested the weekly initial claims data released by the Labor Department.

For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street article.

The Dow Jones Industrial Average (DJI) declined 0.1% to close at 21,397.29. The S&P 500 fell 0.1% to close at 2,434.50. The tech-heavy Nasdaq Composite Index advanced 2.73 points to finish at 6,236.69. The Dow, the S&P 500 and Nasdaq have advanced 8.3%, 8.7% and 15.9% respectively on a year to date basis. A total of around 6.65 billion shares were traded on Thursday, lower than the last 20-session average of 6.95 billion shares. The fear-gauge CBOE Volatility Index (VIX) traded near 10.5. Advancers outnumbered declining stocks on the NYSE by a 1.41 to 1 ratio.

Healthcare Shares Boost Nasdaq

Healthcare shares moved north on Thursday after Senate released the health care Bill in an attempt to revoke and replace Obamacare. The Senate Healthcare Bill proposes to repeal key sections of Obama’s Affordable Care Act including reduction of taxes on high income earners and adjustment of subsidy to poor people for private insurance.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The new Bill won’t change the Obamacare as drastically as the House legislation passed in May, but demands significant cuts that would likely benefit the uninsured. Medicad was expanded by Obamacare, which provided health coverage to millions of low income Americans who couldn’t afford it earlier. The Senate Bill will continue Medicad expansion under Obamacare for the next three years and will roll it back in 2021. But, from now, states won’t receive an open ended funding and instead will receive a fixed amount. The Bill also seeks to stop funding Planned Parenthood, U.S.’s largest reproductive health care provider.

As a result, the broader Health Care Select Sector SPDR (XLV) advanced 1% which ultimately had a positive impact on broader markets. Some of its key holdings, including Gilead Sciences Inc (NASDAQ:GILD) and UnitedHealth Group Inc. (NYSE:UNH) advanced 4.4% and 0.9% respectively. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Financials and Consumer Staples Decline

Financials continued to decline on Thursday, dragged down by fall in shares of banks, insurance companies. Earlier, investors digested several comments made by the central bank officials. Boston Fed President Eric Rosengren expressed his concerns over low interest rates by saying that low interest rates affect financial stability. Speaking at New York University on Monday, Chicago Fed President Charles Evans raised concerns over prevailing levels of inflation and favored gradual monetary tightening.

The broader Financials Select Sector SPDR (XLF) declined 0.6%, which had an adverse impact on the broader markets. Some of its key holdings, including US Bancorp (NYSE:USB) and Goldman Sachs Group Inc (NYSE:GS) fell 1.4% and 1.2% respectively.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, consumer staples shares were also down, neutralizing the effects of strong gain in healthcare shares. The broader Consumer Staples Select Sector SPDR (XLP) fell 0.7%, emerging as one of the worst performing sector of S&P 500.

Economic Data

As per the Labor Department, for the week ending June 17, seasonally adjusted initial claims were recorded at 241,000 against the consensus estimate of 240,000. The figure increased by 3,000 from the earlier week's revised level. The four week moving average was recorded at 244,750, higher than the previous week's revised average figure.

Stocks that made Headlines

Eni Fortifies Position in Kazakhstan with Strategic Tie-Ups

Eni SpA (NYSE:E) has inked an agreement with JSC KazMunayGas (“KMG”) at the Foreign Investors’ Council in Astana. (Read More)

Bed Bath & Beyond Q1 Earnings & Sales Lag, Stock Dips

After making a short-lived comeback in the last quarter, Bed Bath & Beyond Inc. (NASDAQ:BBBY) reverted to a dismal surprise trend in first-quarter fiscal 2017. (Read More)

The Best & Worst of Zacks

Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>



U.S. Bancorp (USB): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Goldman Sachs Group, Inc. (The) (GS): Free Stock Analysis Report

Gilead Sciences, Inc. (GILD): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

ENI (MI:ENI

Bed Bath & Beyond Inc. (BBBY): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.